Cryptosporidium in tap water: Comparison of predicted risks with observed levels of disease

American Journal of Epidemiology

Volumn 147, Issue 3, 1998, Pages 289-301

  Perz, Joseph F ^a   Ennever, Fanny K ^a   Le Blancq, Sylvie M ^a,b  

^a Och Spine at New York Presbyterian Hospitals   (United States)

^b Columbia School of Public Health ^*  (United States)

Author keywords

Acquired immunodeficiency syndrome; Cryptosporidiosis; Cryptosporidium parvum; Diarrhea; Risk assessment; Water; Water microbiology

Indexed keywords

TAP WATER;

ACQUIRED IMMUNE DEFICIENCY SYNDROME; ARTICLE; CRYPTOSPORIDIOSIS; CRYPTOSPORIDIUM PARVUM; DIARRHEA; DISEASE TRANSMISSION; ENDEMIC DISEASE; HUMAN; INFECTION; MATHEMATICAL MODEL; MICROBIOLOGY; NORMAL HUMAN; OOCYST; RISK ASSESSMENT;

EID: 0032005454     PISSN: 00029262     EISSN: None     Source Type: Journal    
DOI: 10.1093/oxfordjournals.aje.a009449     Document Type: Article

References (63)

1. Payment P, Siemiatycki J, Richardson L, et al. A prospective epidemiological study of gastrointestinal health effects due to the consumption of drinking water. Int J Environ Health Res 1997;7:5-31.
2. Environmental Protection Agency. National primary drinking water regulations: enhanced surface drinking water treatment requirements; proposed rule. (Code of Federal Regulations, volume 40: protection of environment. Parts 141 and 142). Washington, DC: Office of the Federal Register, National Archives and Records Service, 1994.
3. Centers for Disease Control and Prevention. Assessing the public health threat associated with waterborne cryptosporidiosis: report of a workshop. MMWR Morb Mortal Wkly Rep 1995;44:1-19.
4. Meinhardt PL, Casemore DP, Miller KB. Epidemiologic aspects of human cryptosporidiosis and the role of waterborne transmission. Epidemiol Rev 1996;18:118-36.
5. ILSI Risk Science Institute Pathogen Risk Assessment Working Group. A conceptual framework to assess the risks of human disease following exposure to pathogens. Risk Anal 1996;16:841-8.
6. Current WL, Garcia LS. Cryptosporidiosis. Clin Microbiol Rev 1991;4:325-58.
7. Ungar BL. Cryptosporidiosis in humans (Homo sapiens). In: Dubey JP, Speer CA, Payer R, eds. Cryptosporidiosis of man and animals. Boston, MA: CRC Press, 1990:59-82.
8. Kuhls TH, Mosier DA, Crawford DL, et al. Seroprevalence of cryptosporidial antibodies during infancy, childhood, and adolescence. Clin Infect Dis 1994;18:731-5.
9. DuPont HL, Chappell CL, Sterling CR, et al. The infectivity of Cryptosporidium parvum in healthy volunteers. N Engl J Med 1995;332:855-9.
10. Juranek DD. Cryptosporidiosis: sources of infection and guidelines for prevention. Clin Infect Dis 1995;21(suppl):S57-61.
11. Goldstein ST, Juranek DD, Ravenholt O, et al. Cryptosporidiosis: an outbreak associated with drinking water despite state-of-the-art water treatment. Ann Intern Med 1996;124: 459-68.
12. Colford JM Jr, Tager IB, Hirozawa AM, et al. Cryptosporidiosis among patients infected with human immunodeficiency virus: factors related to symptomatic infection and survival. Am J Epidemiol 1996;144:807-16.
13. Centers for Disease Control and Prevention. Foodborne outbreak of diarrheal illness associated with Cryptosporidium parvum - Minnesota, 1995. MMWR Morb Mortal Wkly Rep 1996;45:783-4.
14. Sorvillo FJ, Lieb LE, Kerndt PR, et al. Epidemiology of cryptosporidiosis among persons with acquired immunodeficiency syndrome in Los Angeles County. Am J Trop Med Hyg 1994;51:326-31.
15. Pedersen C, Danner S, Lazzarin A, et al. Epidemiology of cryptosporidiosis among European AIDS patients. Genitourin Med 1996;72:128-31.
16. Vakil NB, Schwartz SM, Buggy BP, et al. Biliary cryptosporidiosis in HIV-infected people after the waterbome outbreak of cryptosporidiosis in Milwaukee. N Engl J Med 1996;334:19-23.
17. Frost FJ, Craun GF, Calderon RL. Waterborne disease surveillance. J AWWA 1996;88:66-75.
18. Mac Kenzie WR, Hoxie NJ, Proctor ME, et al. A massive outbreak in Milwaukee of Cryptosporidium infection transmitted through the public water supply. N Engl J Med 1994;331:161-7.
19. Roefer PA, Monscvitz JT, Rexing DJ. The Las Vegas cryptosporidiosis outbreak. J AWWA 1996;88:95-106.
20. Maguire HC, Holmes E, Hollyer J, et al. An outbreak of cryptosporidiosis in South London: what value the p value? Epidemiol Infect 1995;115:279-87.
21. Slob W. Uncertainty analysis in multiplicative models. Risk Anal 1994;14:571-6.
22. Eisenberg JN, Seto EY, Olivieri AW, et al. Quantifying water pathogen risk in an epidemiological framework. Risk Anal 1996;16:549-63.
23. Rose JB, Gerba CP, Jakubowski W. Survey of potable water supplies for Cryptosporidium and Giardia. Environ Sci Technol 1991;25:1393-400.
24. LeChevallier MW, Norton WD, Lee RG. Giardia and Cryptosporidium spp. in filtered drinking water supplies. Appl Environ Microbiol 1991;57:2617-21.
25. LeChevallier MW, Norton WD. Giardia and Cryptosporidium in raw and finished water. J AWWA 1995;87:54-68.
26. New York City Department of Environmental Protection. DEP pathogen studies of Giardia spp., Cryptosporidium spp., and enteric viruses: semi-annual report. (Report to the Environmental Protection Agency, January 31, 1997). New York, NY: Department of Environmental Protection, 1997.
27. Centers for Disease Control and Prevention. 1993 revised classification system for HIV infection and expanded surveillance case definition for AIDS among adolescents and adults. MMWR Morb Mortal Wkly Rep 1992;41:1-19.
28. Office of AIDS Surveillance, New York City Department of Health. AIDS in New York City. (AIDS surveillance update - second quarter 1996). New York, NY: New York City Department of Health, 1996.
29. Roseberry AM, Burmaster DE. Lognormal distributions for water intake by children and adults. Risk Anal 1992;12:99-104.
30. Pennington JA. Revision of the Total Diet Study food list and diets. J Am Diet Assoc 1983;82:166-73.
31. Haas CN, Crockett CS, Rose JB, et al. Assessing the risk posed by oocysts in drinking water. J AWWA 1996;88:131-6.
32. Weber R, Bryan RT, Bishop HS, et al. Threshold of detection of Cryptosporidium oocysts in human stool specimens: evidence for low sensitivity of current diagnostic methods. J Clin Microbiol 1991;29:1323-7.
33. Benhamou Y, Kapel N, Hoang C, et al. Inefficacy of intestinal secretory immune response to Cryptosporidium in acquired immunodeficiency syndrome. Gastroenterology 1995;108:627-35.
34. Hashmey R, Smith NH, Cron S, et al. Cryptosporidiosis in Houston, Texas: a report of 95 cases. Medicine 1997;76:118-39.
35. Boyce TG, Pemberton AG, Addiss DG. Cryptosporidium testing practices among clinical laboratories in the United States. Pediatr Infect Dis J 1996;15:87-8.
36. Morin CA, Roberts CL, Mshar PA, et al. What do physicians know about Cryptosporidiosis? A survey of Connecticut physicians. Arch Intern Med 1997;157:1017-22.
37. Park SI, Giannella RA. Approach to the adult patient with acute diarrhea. Gastroenterol Clin North Am 1993;22:483-97.
38. Guerrant RL, Bobak DA. Bacterial and protozoal gastroenteritis. N Engl J Med 1991;325:327-40.
39. Zar JH. Biostatistical analysis. 2nd ed. Englewood Cliffs, NJ: Prentice-Hall, 1984.
40. Cordell RL, Addiss DG. Cryptosporidiosis in child care settings: a review of the literature and recommendations for prevention and control. Pediatr Infect Dis J 1994;13:310-17.
41. Chappell CL, Okhuysen PC, Sterling CR, et al. Cryptosporidium parvum: intensity of infection and oocyst excretion patterns in healthy volunteers. J Infect Dis 1996;173:232-6.
42. Wuhib T, Suva TM, Newman RD, et al. Cryptosporidial and microsporidial infections in human immunodeficiency virus-infected patients in northeastern Brazil. J Infect Dis 1994;170:494-7.
43. O'Donoghue PJ. Cryptosporidium and Cryptosporidiosis in man and animals. Int J Parasitol 1995;25:139-95.
44. Flanigan T, Whalen C, Turner J, et al. Cryptosporidium infection and CD4 counts. Ann Intern Med 1992;116:840-2.
45. Talley NJ, Zinsmeister AR, Melton LJ 3d. Irritable bowel syndrome in a community: symptom subgroups, risk factors, and health care utilization. Am J Epidemiol 1995;142:76-83.
46. Public Health Laboratory Service Study Group. Cryptosporidiosis in England and Wales: prevalence and clinical and epidemiological features. BMJ 1990;300:774-7.
47. Glass RI, Lew JF, Gangarosa RE, et al. Estimates of morbidity and mortality rates for diarrheal diseases in American children. J Pediatr 1991;118(suppl):S27-33.
48. Garthright WE, Archer DL, Kvenberg JE. Estimates of incidence and costs of intestinal infectious diseases in the United States. Public Health Rep 1988;103:107-15.
49. Chitkara YK, McCasland KA, Kenefic L. Development and implementation of cost-effective guidelines in the laboratory investigation of diarrhea in a community hospital. Arch Intern Med 1996;156:1445-8.
50. Laney DW Jr, Cohen MB. Approach to the pediatric patient with diarrhea. Gastroenterol Clin North Am 1993;22:499-516.
51. Smith PD. Infectious diarrheas in patients with AIDS. Gastroenterol Clin North Am 1993;22:535-48.
52. Dieterich DT, Poles MA, Lew EA. Gastrointestinal manifestations of HIV disease. In: Broder S, Merigan TC Jr, Bolognesi D, eds. Textbook of AIDS medicine. Baltimore, MD: Williams and Wilkins, 1994:541-54.
53. Clavel A, Arnal AC, Sanchez EC, et al. Evaluation of the optimal number of faecal specimens in the diagnosis of cryptosporidiosis in AIDS and immunocompetent patients. Eur J Clin Microbiol Infect Dis 1995;14:46-9.
54. Bureau of Water Supply and Wastewater Collection, New York City Department of Environmental Protection. Active disease surveillance reports for giardiasis and Cryptosporidiosis. (Filtration avoidance deliverables no. 703 - quarterly report no. 11). New York, NY: Department of Environmental Protection, 1996.
55. Bureau of Water Supply and Wastewater Collection, New York City Department of Environmental Protection. Active disease surveillance reports for giardiasis and Cryptosporidiosis. (Filtration avoidance deliverables no. 703 - quarterly report no. 12). New York, NY: Department of Environmental Protection, 1996.
56. Miller JR, Ashendorff A, Seeley A, et al. Descriptive epidemiology of Cryptosporidiosis in New York City, 1995. In: Fricker CR, Clancy JL, Rochelle PA, eds. 1997 International Symposium on Waterborne Cryptosporidium. Newport Beach, CA: American Water Works Association, 1997:317-28.
57. Haas CN, Rose JB. Reconciliation of microbial risk models and outbreak epidemiology: the case of the Milwaukee outbreak. In: Proceedings of the annual conference of the American Water Works Association, New York City, June 1994. Denver, CO: American Water Works Association, 1994: 517-23.
58. Kissel J, Samadpour M, Ongerth J. Comparison of estimated risks of Giardia and Cryptosporidium in drinking water with observations in the Pacific Northwest. In: Proceedings of the annual conference of the American Water Works Association, Toronto, Ontario, Canada, June 1996. Denver, CO: American Water Works Association, 1996:751-7.
59. Teunis PF, Medema GJ, Havelaar AH. Assessment of the risk of infection by Cryptosporidium and Giardia in drinking water from a surface water source. Water Res 1997;31:1333-46.
60. Bureau of Water Supply and Wastewater Collection, New York City Department of Environmental Protection. Active disease surveillance reports for giardiasis and cryptosporidiosis. (Filtration avoidance deliverables no. 703 - quarterly report no. 17). New York, NY: Department of Environmental Protection, 1997.
61. Centers for Disease Control and Prevention. Summary - cases of selected notifiable diseases, United States, cumulative, week ending June 29, 1996 (26th week). (Table). MMWR Morb Mortal Wkly Rep 1996;45(26):573.
62. Centers for Disease Control and Prevention. Summary -provisional cases of selected notifiable diseases, United States, cumulative, week ending June 28, 1997 (26th week). (Table). MMWR Morb Mortal Wkly Rep 1997;46(26):609.
63. Centers for Disease Control and Prevention. Update: trends in AIDS incidence, deaths, and prevalence - United States, 1996. MMWR Morb Mortal Wkly Rep 1997;46:165-73.